Search GLEAM-DB / CoGenEx-PM3
Advanced search and filters
Input query
Recognized gene
ACADVL, ALMS1, ATM, CEP290, CSF2RB and 9 more
Normalized c.HGVS
c.1102C>G, c.1120C>G, c.1366G>A, c.1436A>G, c.149C>T and 45 more
Normalized p.HGVS
p.(=), p.(Ala1110Thr), p.(Ala1421Thr), p.(Arg1237Leu), p.(Arg2285His) and 44 more
Matching records
2686
PM3-positive records
0
Results are ordered by PM3-relevant evidence first. Reviewed source only indicates whether main text, supplementary material, or both were reviewed; it is not the evidence conclusion.
| Gene | Variant | Evidence | PM3 context | Publication | Reviewed source | Actions |
|---|---|---|---|---|---|---|
| ANK3 |
NM_020987.5:c.1375C>T
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
41417832
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.
Cancer research communications, 2026
|
Main article | |
| FANCA |
NM_000135.4:c.1874G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
40111122
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia.
Cancer research communications, 2025
|
Main article | |
| MSH2 |
NM_000251.3:c.1145G>C
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
39656055
Variant of Uncertain Significance Patterns among Patients with Early-Onset Colorectal Cancer.
Cancer research communications, 2024
|
Main article | |
| MSH2 |
NM_000251.3:c.1145G>T
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
39656055
Variant of Uncertain Significance Patterns among Patients with Early-Onset Colorectal Cancer.
Cancer research communications, 2024
|
Main article | |
| MSH2 |
NM_000251.3:c.2179G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
39656055
Variant of Uncertain Significance Patterns among Patients with Early-Onset Colorectal Cancer.
Cancer research communications, 2024
|
Main article | |
| MSH2 |
NM_000251.3:c.2179G>C
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
39656055
Variant of Uncertain Significance Patterns among Patients with Early-Onset Colorectal Cancer.
Cancer research communications, 2024
|
Main article | |
| BRCA1 |
NM_007294.4:c.4780C>G
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
38282550
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Cancer research communications, 2024
|
Main article and supplement | |
| BRCA1 |
NM_007294.4:c.4780C>T
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
38282550
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Cancer research communications, 2024
|
Main article and supplement | |
| MSH6 |
NM_000179.3:c.1063G>C
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
37910143
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.
Cancer research communications, 2023
|
Main article and supplement | |
| ATM |
NM_000051.4:c.1079A>G
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
37637936
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs.
Cancer research communications, 2023
|
Main article | |
| ATM |
NM_000051.4:c.1079A>T
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
37637936
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs.
Cancer research communications, 2023
|
Main article | |
| ATM |
NM_000051.4:c.743G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
37637936
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs.
Cancer research communications, 2023
|
Main article | |
| ATM |
NM_000051.4:c.1369C>G
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
37377903
Multiple Germline Events Contribute to CancerĀ Development in Patients with Li-Fraumeni Syndrome.
Cancer research communications, 2023
|
Main article and supplement | |
| ATM |
NM_000051.4:c.7271T>C
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
37377903
Multiple Germline Events Contribute to CancerĀ Development in Patients with Li-Fraumeni Syndrome.
Cancer research communications, 2023
|
Main article and supplement | |
| PMS2 |
NM_000535.7:c.1961C>T
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
36875157
Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.
Cancer research communications, 2023
|
Main article | |
| ATM |
NM_000051.4:c.3385G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
36969747
Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.
Cancer research communications, 2022
|
Main article and supplement | |
| FANCA |
NM_000135.4:c.1153C>G
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
36969747
Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.
Cancer research communications, 2022
|
Main article and supplement | |
| CD79A |
NM_001783.4:c.371G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
36969747
Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.
Cancer research communications, 2022
|
Main article and supplement | |
| PAX5 |
NM_016734.3:c.914G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
36969747
Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.
Cancer research communications, 2022
|
Main article and supplement | |
| ACADVL |
NM_000018.4:c.95G>A
|
No PM3 Evidence Identified
Not assessed
|
No PM3 candidate genotype identified |
36922933
Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.
Cancer research communications, 2022
|
Main article and supplement | |